Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jie Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-6706-8033; OpenAlex author ID A5109799194. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2023: 1 paper · 2024: 6 papers · 2025: 1 paper

Papers 8

  1. Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer. Co-author DOI 10.1186/s12885-024-13374-4↗
  2. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.216649↗
  3. Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gendis.2023.101143↗
  4. Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis. Co-author DOI 10.1128/spectrum.00962-24↗
  5. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, an… Co-author DOI 10.1186/s12967-024-05158-y↗
  6. CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. Co-author DOI 10.1186/s13046-024-03201-w↗
  7. Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic can… First author DOI 10.3389/fimmu.2024.1435593↗
  8. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. Co-author DOI 10.1186/s13046-023-02698-x↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yupei Zhao · 8 shared papers, 2023–2025 · strength 1.65
  2. Lei You · 8 shared papers, 2023–2025 · strength 1.65
  3. Bo Ren · 7 shared papers, 2023–2025 · strength 1.42
  4. Yuan Fang · 3 shared papers, 2023–2024 · strength 0.61
  5. Xing Wang · 3 shared papers, 2023–2025 · strength 0.60
  6. Gang Yang · 3 shared papers, 2023–2024 · strength 0.55
  7. Jinshou Yang · 2 shared papers, 2023–2024 · strength 0.39
  8. Xing Wang · 1 shared paper, 2024 · strength 0.23
  9. Xiaohong Liu · 1 shared paper, 2025 · strength 0.22
  10. Xing Wang · 1 shared paper, 2024 · strength 0.21
  11. Xiaohong Liu · 1 shared paper, 2024 · strength 0.20
  12. Ming Cui · 1 shared paper, 2024 · strength 0.20
  13. Xing Wang · 1 shared paper, 2024 · strength 0.20
  14. Tao Liu · 1 shared paper, 2024 · strength 0.16
  15. Jianchun Xiao · 1 shared paper, 2024 · strength 0.16
  16. Jinxin Tao · 1 shared paper, 2024 · strength 0.16
  17. Wenhao Luo · 1 shared paper, 2024 · strength 0.16
  18. Hua Huang · 1 shared paper, 2024 · strength 0.16
  19. Zhe Cao · 1 shared paper, 2024 · strength 0.16
  20. Yifan Fu · 1 shared paper, 2024 · strength 0.16
  21. Dan Su · 1 shared paper, 2024 · strength 0.16
  22. Jiangdong Qiu · 1 shared paper, 2024 · strength 0.16
  23. Taiping Zhang · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.